Taylor Leamey writes about all things wellness, specializing in mental health, sleep and nutrition coverage. She has invested hundreds of hours into studying and researching sleep and holds a ...

North East London Cancer Alliance is leading a project to integrate AI into cancer diagnostic pathways The alliance is using the Sectra Amplifier services and the Qure X-ray AI tool to help ...

Aaron Chown - Pool/Getty Queen Camilla has canceled multiple scheduled appearances this week after falling ill with a chest infection, Buckingham Palace says. "Her Majesty The Queen is currently ...

Queen Camilla, wife of Britain's King Charles III, has been forced to pull out of her planned engagements this week after suffering a chest infection, Buckingham Palace said on Tuesday.

Echo parameters: The beneficial effect of transcatheter mitral valve replacement compared with GDMT alone was consistent in all echocardiographic subgroups, independent of the severity of LV ...

For patients with symptomatic and severe or greater tricuspid regurgitation (TR), transcatheter tricuspid valve replacement (TTVR) plus optimal medical therapy (OMT) yields substantial improvement ...

More information: Rebecca T. Hahn et al, Transcatheter Valve Replacement in Severe Tricuspid Regurgitation, New England Journal of Medicine (2024). DOI: 10.1056/NEJMoa2401918 ...

View all available purchase options and get full access to this article.

Aortic regurgitation occurs when blood leaks back ... The condition may be asymptomatic at first, but it can cause chest pain, trouble breathing, and fainting. Treatment can involve medications ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

Severe tricuspid regurgitation is associated with disabling symptoms and an increased risk of death. Data regarding outcomes after percutaneous transcatheter tricuspid-valve replacement are needed.

Innoventric, a leader in transcatheter tricuspid regurgitation (TR) treatment, today announced a $28.5 million Series B funding round to advance its revolutionary cross-caval technology, bringing the ...